Tag Archives: Super Committee

Obama Deficit Plan Sides With PBMs Over Big Pharma

By Ben Comer | Published: September 20, 2011
Amid the flurry of cost-cutting proposals aimed at guiding the Joint Select Committee on Deficit Reduction’s (Super Committee) budgetary blade, the Obama Administration has now weighed in with a proposal to cut $248 billion from Medicare spending over ten years, and $73 billion in Medicaid and other health-related spending. The Obama plan, which would increase [...]
Posted in Regulatory, Strategy, healthcare, leadership | Also tagged , , , , | Leave a comment

PBMs to Super Committee: Take $100 Billion From Pharma

By Ben Comer | Published: September 7, 2011
A trade group representing the largest pharmacy benefits managers (PBMs) has proposed a way to trim $100 billion in government costs for prescription drugs over 10 years. To the pharmaceutical industry, that trim might look more like a beheading.
Posted in Marketing, Regulatory, Strategy, healthcare, leadership, pricing | Also tagged , , , , | 2 Comments

Pharma's Influence on the Super Committee: Is Cash Really King?

By Ben Comer | Published: August 16, 2011
Three of the twelve appointees to the Joint Select Committee on Deficit Reduction (aka Super Committee) received over $300,000 in campaign contributions from pharmaceutical companies, according to Center for Responsive Politics data, and a MapLight analysis.
Posted in Strategy, healthcare, leadership | Also tagged , , , , , | 1 Comment